BREA, CA – NuLiv Science announces the launch of its newly rebranded sports nutraceutical compound, Senactiv®.
The ingredient, formerly known as ActiGin®, is scientifically validated with 2 in-vivo and 4 human clinical studies with 6 interventions evaluated. Senactiv® enhances physical performance through energy nourishment and optimized cell turnover specifically in exercised muscle tissue.
Along with a new clinical study featured soon (pending publication) in the journal, Aging, Senactiv® is uniquely positioned to be the catalyst for boosting human performance in the context of healthy aging and exercise.
“With our newest research on senescent cell clearance in exercised muscle tissue and our research plan for the future we felt it was a great time to reposition and refresh the brand of this incredible ingredient”, shared Josh Beaty, Marketing Director. “Muscle energy and muscle regeneration are the key value propositions, and we know consumers are actively seeking these outcomes.”
New research means massive innovation ahead for supplement product formulators.
NuLiv Science President, Richard Wang added, “We have now found a way to slow down muscle aging… and we know muscle strength and muscle mass is an important indicator of healthy aging for consumers”.
The ingredient is available and product formulators are encouraged to visit Senactiv®’s ingredient page to review the scientific studies.
NuLiv Science specializes in the research and development of proprietary and clinically proven nutraceutical ingredients via traditional and scientific processes. Since 1997, the company has served customers’ sourcing and research needs with an emphasis on quality and efficacy.